sorafenib has been researched along with Stasis Ulcer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, Y; Ikehara, T; Kaneko, R; Kitajima, M; Matsuda, T; Nagai, H; Ogino, H; Uekusa, T | 1 |
1 other study(ies) available for sorafenib and Stasis Ulcer
| Article | Year |
|---|---|
A case of multiple hepatocellular carcinoma experiencing complete responses to sorafenib and atezolizumab-bevacizumab and developing severe, refractory venous congestive cutaneous ulcers on either regimen.
Topics: Angiogenesis Inhibitors; Bevacizumab; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Sorafenib; Ulcer; Varicose Ulcer; Vascular Endothelial Growth Factor A | 2023 |